Table 1 Clinicopathologic and treatment characteristics of 184 patients with mid/low rectal cancer
Variable | TME group [cases (%)] | CCRT + TME group [cases (%)] | P value |
|---|---|---|---|
Total | 94 | 90 | Â |
Age (years) | |||
 ≤ 60 | 62 (66.0) | 64 (71.1) | 0.452 |
 > 60 | 32 (34.0) | 26 (28.9) |  |
Sex | 0.273 | ||
 Male | 51 (54.3) | 56 (62.2) |  |
 Female | 43 (45.7) | 34 (37.8) |  |
DAV (cm) | 0.290 | ||
 ≤ 5 | 47 (50.0) | 52 (57.8) |  |
 > 5 | 47 (50.0) | 38 (42.2) |  |
cTNM stage | 0.097 | ||
 II | 48 (51.1) | 33 (36.7) |  |
 III | 46 (48.9) | 57 (63.3) |  |
Type of resection | 0.849 | ||
 LAR | 67 (71.3) | 63 (70.0) |  |
 APR | 27 (28.7) | 27 (30.0) |  |
pT stage | < 0.001 | ||
 pT0–2 | 22 (23.4) | 56 (62.2) |  |
 pT3–4 | 72 (76.6) | 34 (37.8) |  |
pN stage | 0.005 | ||
 pN0 | 55 (58.5) | 70 (77.8) |  |
 pN1–2 | 39 (41.5) | 20 (22.2) |  |
pTNM stage | < 0.001 | ||
 pT0N0M0 | 0 | 32 (35.6) |  |
 pT1–2N0M0 | 16 (17.0) | 17 (18.9) |  |
 pT3–4N0M0 | 39 (41.5) | 21 (23.3) |  |
 pT1–4N1–2M0 | 39 (41.5) | 20 (22.2) |  |
Adjuvant chemotherapy | < 0.001 | ||
 Yes | 61 (64.9) | 79 (87.8) |  |
 No | 33 (35.1) | 11 (12.2) |  |
Cycles of perioperative chemotherapy | |||
 1–7 | 52 (55.3) | 56 (62.2) | 0.342 |
 8 | 42 (44.7) | 34 (37.8) |  |